Repression of <i>SLC22A3</i> by the <scp>AR‐V7</scp> / <scp>YAP1</scp> / <scp>TAZ</scp> axis in enzalutamide‐resistant castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Repression of SLC22A3 by the AR‐V7 / YAP1 / TAZ axis in enzalutamide‐resistant castration‐resistant prostate cancer

Published:2022-10-30 Issue:6 Volume:290 Page:1645-1662
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Seo Eunjeong¹,Jee Byula¹,Chung Jae Hoon¹,Song Wan¹,Sung Hyun Hwan¹,Jeon Hwang Gyun¹,Jeong Byong Chang¹,Seo Seong Il¹,Jeon Seong Soo¹,Lee Hyun Moo¹,Kang Minyong¹²³^ORCID

Affiliation:

1. Department of Urology, Samsung Medical Center, School of Medicine Sungkyunkwan University Seoul Korea

2. Department of Health Sciences and Technology, SAIHST Sungkyunkwan University Seoul Korea

3. Samsung Genome Institute Samsung Medical Center Seoul Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16657

Reference45 articles.

1. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

2. Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models

3. Role of Androgen Receptor in Prostate Cancer: A Review

4. Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

5. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An anti-neoplastic tale of metformin through its transport;Life Sciences;2024-09

2. Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment;Nanomedicine;2024-03-29

3. Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer;Journal of Clinical Medicine;2023-05-09